Abstract
Hyperparameter optimization (HPO) can materially affect the performance of deep learning (DL) image classifiers, but there is little empirical guidance on how to derive the validation signal that drives it, especially for the small sample sizes common in fields such as medical imaging. We compared three HPO protocols in terms of {\em absolute performance-estimation error} (AEE; the absolute difference between the winning configuration's validation AUROC and its test AUROC): fixed holdout (F), reshuffled holdout (R), and 5-fold cross-validation (C). The search space, sampler, training procedure, architecture, and test set were held identical across protocols. We evaluated the protocols on three public datasets spanning two regimes: binary medical imaging (RSNA pneumonia radiographs and binarized HAM10000 skin lesions) and 200-class natural imaging (Tiny ImageNet), across a range of development set sizes $n$ and two backbones (ResNet-18 on all datasets, Vision Transformer (ViT-S/16) on RSNA). On the medical datasets, every point estimate favored cross-validation over both holdout protocols, with reductions in AEE largest at small sample sizes and diminishing as $n$ increased. This pattern remained robust under conservative family-wise adjustment. On Tiny ImageNet, AEE was negligible under all three protocols. Test AUROC was generally similar among protocols. Fixed holdout had lower mean AEE than reshuffled holdout in 11 of 12 medical conditions, although this secondary finding was less uniformly supported. For small-sample medical image classification, we recommend cross-validation-based HPO when computational resources permit because it trades additional computation for a more reliable development-time estimate of subsequent test performance.
Abstract (translated)
URL
https://arxiv.org/abs/2608.14705
